Glaucoma drug may have potential to treat Alzheimer's disease

December 9, 2016 by Margaret-Anne Orgill, University College London
Credit: University College London

A drug which is used to treat the common eye disease glaucoma may have potential as a treatment for Alzheimer's disease, according to scientists at UCL.

In trials on rats, the drug brimonidine, which is routinely used to lower eye pressure in glaucoma patients, has been found to reduce the formation of in the retina, which are believed to be linked to Alzheimer's. The research was reported in the journal Cell Death and Disease.

Amyloid plaques can be seen in the retinas of people with Alzheimer's, so the researchers say the retina can be viewed as an extension of the brain that provides an opportunity to diagnose and track progression of Alzheimer's.

Scientists found that brimonidine reduces neurodegeneration of cells in the retina by cutting the levels of beta amyloid in the eye. This was achieved by using the drug to stimulate the production of an alternative non-toxic protein which does not kill .

The researchers hope that the drug will have a similar effect on the brain, although this was not tested in the current study.

"The findings of our study could not have come at a more significant and important moment, given the increased prevalence of Alzheimer's disease.  As we live longer, there will be increasing demand for therapies that can help challenge this extremely damaging and we believe that our findings can make a major contribution," said Professor Francesca Cordeiro (UCL Institute of Ophthalmology) who led the study.

Explore further: 'Pac-Man' gene implicated in Alzheimer's disease

More information: Shereen Nizari et al. Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection, Cell Death and Disease (2016). DOI: 10.1038/cddis.2016.397

Related Stories

'Pac-Man' gene implicated in Alzheimer's disease

July 26, 2016
A gene that protects the brain from the harmful build-up of amyloid-beta, one of the causative proteins implicated in Alzheimer's disease, has been identified as a new target for therapy by NeuRA researchers.

Experimental drug shows promise in treating Alzheimer's disease

October 25, 2016
An experimental drug shows promise in treating Alzheimer's disease by preventing inflammation and removing abnormal protein clumps in the brain that are associated with the disease, suggests a study in mice presented at the ...

Alzheimer's detected before symptoms via new eye technology

July 11, 2016
Rockville, Md. Scientists may have overcome a major roadblock in the development of Alzheimer's therapies by creating a new technology to observe—in the back of the eye—progression of the disease before the onset of symptoms. ...

Cannabinoids remove plaque-forming Alzheimer's proteins from brain cells

June 29, 2016
Salk Institute scientists have found preliminary evidence that tetrahydrocannabinol (THC) and other compounds found in marijuana can promote the cellular removal of amyloid beta, a toxic protein associated with Alzheimer's ...

Recommended for you

Scientists discover why some people with brain markers of Alzheimer's have no dementia

August 16, 2018
A new study from The University of Texas Medical Branch at Galveston has uncovered why some people that have brain markers of Alzheimer's never develop the classic dementia that others do. The study is now available in the ...

Researchers identify new genes that may contribute to Alzheimer's disease

August 14, 2018
Researchers from Boston University School of Medicine, working with scientists across the nation on the Alzheimer's Disease Sequencing Project (ADSP), have discovered new genes that will further current understanding of the ...

Deaths from resident-to-resident incidents in dementia offers insights to inform policy

August 14, 2018
Analyzing the incidents between residents in dementia in long-term care homes may hold the key to reducing future fatalities among this vulnerable population, according to new research from the University of Minnesota School ...

Scientists propose a new lead for Alzheimer's research

August 14, 2018
A University of Adelaide-led team of scientists has suggested a potential link between iron in our cells and the rare gene mutations that cause Alzheimer's disease, which could provide new avenues for future research.

Eye conditions provide new lens screening for Alzheimer's disease

August 8, 2018
Alzheimer's disease is difficult to diagnose as well as treat, but researchers now have a promising new screening tool using the window to the brain: the eye.

Potential indicator for the early detection of dementias

August 7, 2018
Researchers at the University of Basel have discovered a factor that could support the early detection of neurodegenerative diseases such as Alzheimer's or Parkinson's. This cytokine is induced by cellular stress reactions ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.